Neuberger Berman Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319M | Sell |
|
|||||
|
2025
Q1 | $276M | Sell |
|
|||||
|
2024
Q4 | $345M | Buy |
|
|||||
|
2024
Q3 | $324M | Buy |
|
|||||
|
2024
Q2 | $317M | Buy |
|
|||||
|
2024
Q1 | $323M | Buy |
|
|||||
|
2023
Q4 | $302M | Sell |
|
|||||
|
2023
Q3 | $320M | Sell |
|
|||||
|
2023
Q2 | $304M | Sell |
|
|||||
|
2023
Q1 | $303M | Sell |
|
|||||
|
2022
Q4 | $305M | Sell |
|
|||||
|
2022
Q3 | $288M | Buy |
|
|||||
|
2022
Q2 | $242M | Sell |
|
|||||
|
2022
Q1 | $238M | Sell |
|
|||||
|
2021
Q4 | $205M | Buy |
|
|||||
|
2021
Q3 | $270M | Buy |
|
|||||
|
2021
Q2 | $249M | Buy |
|
|||||
|
2021
Q1 | $314M | Buy |
|
|||||
|
2020
Q4 | $336M | Sell |
|
|||||
|
2020
Q3 | $252M | Sell |
|
|||||
|
2020
Q2 | $278M | Buy |
|
|||||
|
2020
Q1 | $265M | Buy |
|
|||||
|
2019
Q4 | $300M | Buy |
|
|||||
|
2019
Q3 | $285M | Buy |
|
|||||
|
2019
Q2 | $262M | Buy |
|
|||||
|
2019
Q1 | $142M | Buy |
|
|||||
|
2018
Q4 | $142M | Sell |
|
|||||
|
2018
Q3 | $170M | Sell |
|
|||||
|
2018
Q2 | $136M | Sell |
|
|||||
|
2018
Q1 | $127M | Sell |
|
|||||
|
2017
Q4 | $113M | Sell |
|
|||||
|
2017
Q3 | $92.1M | Buy |
|
|||||
|
2017
Q2 | $73.6M | Sell |
|
|||||
|
2017
Q1 | $81.5M | Buy |
|
|||||
|
2016
Q4 | $73.3M | Sell |
|
|||||
|
2016
Q3 | $68.1M | Sell |
|
|||||
|
2016
Q2 | $55.8M | Sell |
|
|||||
|
2016
Q1 | $81.3M | Sell |
|
|||||
|
2015
Q4 | $77M | Sell |
|
|||||
|
2015
Q3 | $120M | Sell |
|
|||||
|
2015
Q2 | $172M | Sell |
|
|||||
|
2015
Q1 | $203M | Sell |
|
|||||
|
2014
Q4 | $183M | Sell |
|
|||||
|
2014
Q3 | $180M | Sell |
|
|||||
|
2014
Q2 | $195M | Sell |
|
|||||
|
2014
Q1 | $185M | Sell |
|
|||||
|
2013
Q4 | $241M | Sell |
|
|||||
|
2013
Q3 | $240M | Sell |
|
|||||
|
2013
Q2 | $255M | Buy |
|